SCHEMBL28529772

SCHEMBL28529772

CC(N[P@@](=O)(Oc1c(F)c(F)c(F)c(F)c1F)Oc1cccc2ccccc12)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ PGR P06401 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ BTN3A1 O00481 2/20 0.37
▸ HPGD P15428 3/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ OGG1 O15527 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529771 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL23827926 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL20840403 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL21192831 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL2512330 1.00 ALDH1A1 (0.39) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL23044633 0.90 MEN1 (0.39) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL20845948 0.88 BTN3A1 (0.41) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL29692333 0.88 BTN3A1 (0.41) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL30435963 0.88 BTN3A1 (0.41) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL28401524 0.88 BTN3A1 (0.41) ALDH1A1HSD17B10PGRGAAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112442011-A Prodrug compound and application thereof in treating cancer 润佳(苏州)医药科技有限公司 2021-03-05 — — CN disclosed
Send feedback